Navigation Links
Differing Ideas on Management of Alzheimer’s diseas

Doctors allege that memory clinics and drugs to retard the progress of symptoms of Alzheimer's disease are diverting resources from high quality integrated care in state-funded health services.//

The National Institute for Health and Clinical Excellence (NICE) had recommended treatments known as cholinesterase inhibitors for patients with mild-to-moderate Alzheimer's disease since 2001.

However psychiatrist Anthony Pelosi of the Hairmyres Hospital in East Kilbride, Scotland and his colleagues said that memory clinics that were initially set up to prescribe and monitor the medicines have distorted clinical priorities.

Pelosi said, "These clinics are diverting resources from high quality integrated care." He added that these drugs, which cost about 1,000 pounds per patient per year, have been found to be of marginal benefit from statistical, clinical and public health perspectives.

According to Pelosi and his colleagues although memory clinics recruited multidisciplinary staff, there is a shortage of mental health professionals in Britain. In addition the clinics do not offer care in the community for their patients as their illness progresses.

The 2001 decision by NICE stressed that further research would be needed and that the recommendation would be reviewed in several years.

In March 2005, NICE recommended these drugs must be stopped from being given to new patients because they were not cost effective. The Royal College of Psychiatrists and the Association of the British Pharmaceutical Industry condemned the decision, which NICE said was provisional and subject to consultations.

It has been estimated that 12 million people worldwide suffer from Alzheimer's which is the leading cause of dementia in the elderly.

Novartis AG's Exelon; Pfizer Inc and Eisai Co's Aricept; and Reminyl, made by Johnson & Johnson and distributed in Britain by Shire Pharmaceuticals Group are leading cholinesterase in hibitors.

Pelosi added, "Whatever the final outcome of NICE's deliberations, the human and financial resources that have become tied up in clinics organised around prescription of cholinesterase inhibitors must be diverted to old age psychiatry teams and their social care counterparts."


NLA
'"/>




Related medicine news :

1. Differing reactions to anti clotting drugs may be due to genetic variation.
2. New Ideas on Developing Thought-Controlled Artificial Limbs
3. New Modality in Migraine Management
4. Self-Management Program Beneficial for Back Pain
5. Self-Management Program Beneficial for Back Pain
6. Disease Management Programs – Effective for Heart Patient
7. Effective Management Of Heart Patients
8. Gastrin, Much More Than The Weight Management Hormone
9. Medical Management Now Available For Miscarriage
10. Early Awareness About Weight Management Needed To Tackle Lifelong Obesity
11. Exercise For Effective Pain Management In Old People
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ... Success website has recently developed and published an informational resource that addresses frequently ... based on common inquiries the site’s team of third party administrator (TPA) contributors ...
(Date:3/28/2017)... Monica, CA (PRWEB) , ... March 28, 2017 ... ... Dr. Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the ... gastric balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already ...
(Date:3/28/2017)... ... 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ages, ... to offer to the discussion of dealing with excess skin oil. “Oily skin is a ... remedies that can help remove the oily shine while keeping the skin fresh and clean,” ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... New patients ... Braasch for leading sleep apnea treatment, with or without a referral. Sleep apnea is ... which can include daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CAMBRIDGE, Mass. , March 28, 2017  Akcea Therapeutics, ... three additions to the company,s board of directors: ... Bessemer Venture Partners. Mr. Gabrieli will serve as chairman of ... Hochberg , former chief commercial officer of Forest Laboratories. ... of Global Biolink Partners. "We are ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
(Date:3/28/2017)... , March 28, 2017 The ... to reach a value of USD 4.5 billion by ... Research, Inc. Proper closure of injured tissues post operation ... function. Postoperative leakages occur in 3% to 15% of ... are responsible for one third of postoperative deaths in ...
Breaking Medicine Technology: